Tango Therapeutics is a biotechnology company developing novel medicines for patients by discovering and drugging context-dependent vulnerabilities in cancers. Tango was launched in 2017 by Third Rock Ventures, and is headquartered in Cambridge, Mass. For more information, please visit tangotx.com.
Year Invested: 2017
Location: Cambridge, Mass.